Myriad Genetics, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
SALT LAKE CITY, Dec. 28, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference, at 1:30 p.m. Pacific Time on Wednesday, January 11, 2012. The conference is being held at the Westin St. Francis Hotel in San Francisco, California.